February 06, 2009
Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate
presentation will be webcast from the 11th Annual BIO CEO
Investor Conference in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will provide an overview of the company on Tuesday, February 10 at noon
To access the live webcast via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com
call the Gilead Public Affairs Department at
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715